Yes, Nimenrix Can Be Given Now
Yes, it is safe to administer Nimenrix (MenACWY-TT) now—there is no required waiting period between tetanus-containing vaccines and meningococcal conjugate vaccines. The six-month interval since the tetanus shot is more than adequate and poses no safety or immunogenicity concerns.
Key Evidence Supporting Concurrent Administration
The ACIP guidelines explicitly state that MenACWY-D may be given at any time in relation to Tdap or Td 1. While this specific guidance references MenACWY-D (Menactra), the same principle applies to all meningococcal ACWY conjugate vaccines, including Nimenrix (MenACWY-TT), as they share similar immunologic profiles and carrier protein considerations.
Why There's No Interference
Different vaccine platforms: Tetanus-containing vaccines (Tdap, Td, or tetanus toxoid alone) and meningococcal conjugate vaccines can be administered simultaneously or at any interval without immunologic interference 2
Clinical trial evidence: Studies specifically evaluating MenACWY-TT co-administered with Tdap demonstrated non-inferiority for both vaccines, with robust immune responses to all antigens 2
No minimum interval required: Unlike some live vaccines that require spacing, inactivated vaccines like tetanus toxoids and meningococcal conjugates have no minimum interval requirements 3
Important Timing Consideration
The only timing restriction for MenACWY-D specifically is that it should be given before or at the same time as DTaP in young children to avoid interference with the meningococcal immune response 1. However, this does not apply to:
- Tdap or Td vaccines (adolescent/adult formulations)
- Situations where the tetanus vaccine was already given (as in your case)
- Nimenrix (MenACWY-TT), which has a different carrier protein profile
Safety Profile
Nimenrix has demonstrated an excellent safety profile across all age groups in over 17,000 participants 4. When co-administered with other vaccines, including tetanus-containing vaccines, the safety profile remains comparable with no clinically significant concerns 5, 6, 7.
Proceed with administration—the six-month interval is well beyond any theoretical concern and represents standard clinical practice.